Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
12.11
-0.03 (-0.25%)
At close: Sep 26, 2025, 4:00 PM EDT
12.12
+0.01 (0.08%)
After-hours: Sep 26, 2025, 5:21 PM EDT
CRBP Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$50.57
Upside
+317.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +230.31% | Sep 17, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $56 → $53 | Buy | Maintains | $56 → $53 | +337.65% | Aug 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $65 → $58 | Buy | Maintains | $65 → $58 | +378.94% | May 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $56 | Buy | Maintains | $60 → $56 | +362.43% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $40 | Strong Buy | Maintains | $50 → $40 | +230.31% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 → $50 | Strong Buy | Reiterates | $75 → $50 | +312.88% | Mar 12, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $70 → $53 | Strong Buy | Maintains | $70 → $53 | +337.65% | Mar 11, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +519.32% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 → $75 | Strong Buy | Reiterates | $80 → $75 | +519.32% | Feb 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $35 | Buy | Initiates | $35 | +189.02% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +560.61% | Sep 23, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $85 → $40 | Strong Buy | Maintains | $85 → $40 | +230.31% | Sep 20, 2024 |
| Wedbush | Wedbush | Buy Maintains $85 → $51 | Buy | Maintains | $85 → $51 | +321.14% | Sep 20, 2024 |
| Mizuho | Mizuho | Buy Reiterates $74 | Buy | Reiterates | $74 | +511.07% | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +577.13% | Sep 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.